THRIVE

Pre-exposure prophylaxis (or PrEP) is when people at very high risk for HIV take HIV medicines daily to lower their chances of getting infected.

• PrEP 101 [PDF – 637 KB]
• PrEP Fact Sheet [PDF – 131 KB]
• PrEP Clinical Practice Guidelines [PDF – 1.66 MB]

HIV testing is important to identify persons who are HIV positive so they can initiate HIV treatment, and to identify persons who are HIV negative, and if also at substantial risk of acquiring an HIV infection, can be offered PrEP and other risk reduction interventions.

• HIV Testing 101 [PDF – 585 KB]
• HIV Testing Basics
• HIV Screening and Testing
• Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings

nPEP with a 28-day course of daily oral HIV medications lowers the risk of acquiring HIV after a potential exposure to the virus through sexual contact or from needle sharing or a needle stick.

• PEP 101
• nPEP Guidelines [PDF – 1 MB]

Interventions with demonstrated potential to lower the risk of acquiring an HIV infection.

• Effective Interventions HIV Prevention That Works

The HIV care continuum consists of several steps required to achieve a suppressed viral load in the blood: linkage to and engagement in clinical care and taking HIV medications.

• HIV Care Continuum [PDF – 1 MB]